Bioavailability and antioxidant effects of orange juice components in humans. by Franke, Adrian A. et al.
Bioavailability and antioxidant effects of orange juice components
in humans
Adrian A. Franke, Robert V. Cooney, Susanne M. Henning1, and Laurie J. Custer
Cancer Research Center of Hawaii, University of Hawaii, Honolulu, 96813
1Center for Human Nutrition, University of California at Los Angeles, CA 90095
Abstract
Seven healthy females and six males consumed daily 256 mg vitamin C, 229 mg hesperidin (main
flavonoid occurring as glycoside), 6 mg carotenoids (mainly luteins and cryptoxanthins), and 0.16
mg folate by incorporation of daily 236 mL of not-from-concentrate orange juice (OJ) into their
habitual diet. At the end of three weeks mean vitamin C, folate, carotenoid, and flavanone plasma
concentrations increased significantly relative to baseline by 59% (p<0.001), 46% (p=0.018), and
22% (p<0.001), and 8 fold (p=0.045), respectively. Flavanones were excreted in urine 9 fold more
at the end of the intervention (p=0.01) but returned to baseline two days after study completion. After
the 3-week intervention plasma concentrations of vitamins A and E did not change. 8-Hydroxy
deoxyguanosine (8OHdG) in white blood cells declined by 16% (p=0.38; n=11), and in individuals
with high baseline concentrations by 29% (p=0.36; n=7), respectively. LDL-/HDL-cholesterol ratio
decreased but cholesterol (HDL, LDL, total) and thiobarbituric acid reactive substance plasma
concentrations did not change significantly. We conclude from this pilot study that OJ is an excellent
food source to enhance circulating concentrations of valuable hydrophilic as well as lipophilic
phytochemicals.
Keywords
orange juice; antioxidants; vitamins; flavonoids; folate; carotenoids
Oxidative damage is involved in many chronic diseases including the major causes of death in
Western societies such as cardiovascular disorders and cancer (1). Oxidized LDL contributes
to the formation of atherosclerotic lesions and poses an additional oxidant stress that injures
smooth muscle and endothelial cells (2). Adipositiy leads to oxidant stress because intracellular
triglycerides cause increased superoxide formation (3) and stimulate adipocytes or
preadiposites to produce inflammatory cytokines (4) which induce formation of various
oxidative radicals (5). Mutagens and carcinogens may act through the generation of free
radicals which initiate a series of degenerative processes related to cancer, heart disease, and
aging (6). Antioxidants may prevent these degenerative processes by various mechanisms
including scavenging of free radicals. Intake as well as systemic levels of antioxidant
micronutrients are associated with preventing cancer and heart disease in prospective
epidemiologic as well as intervention studies when the exposure occurred through the diet
(7-16). Antioxidants, markers of oxidative damage, and other risk factors like homocysteine,
triglycerides, and LDL-cholesterol are therefore widely accepted surrogate means to assess
risk for heart disease and cancer (17-19).
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Orange juice (OJ) contains an array of potent antioxidants including flavonoids (hesperetin
and naringenin predominantly as glycosides), carotenoids (xanthophylls, cryptoxanthins,
carotenes), and vitamin C in addition to other beneficial phytochemicals, such as folate. All of
these are believed to be significant contributors to the preventive effects of fruits and vegetables
against cancer and heart disease (7,20).
A limited number of reports exists on the bioavailability of antioxidant micronutrients in
humans associated with an assessment of risk markers as a result of OJ intake. After 4 weeks
of the highest OJ dose (750 mL daily), but not at lower doses, circulating vitamin C, folate,
HDL- cholesterol, and triacylglycerol levels were elevated without affecting homocysteine
concentrations as assessed in 25 hypercholesterolemic subjects (21). After 2 weeks of daily
500 mL commercial fresh-squeezed OJ a significant inverse correlations between the plasma
concentration of vitamin C and the isoprostane 8-epi-PGF2α, a marker for oxidative damage
to lipids, was reported from 12 subjects (22). After 2 weeks of daily 237 or 472 mL OJ or
supplemental vitamin C equivalent to the lower OJ dose were equally effective at increasing
circulating vitamin C concentrations and at reducing plasma lipid peroxidation as measured
by thiobarbituric reactive substances (TBARS) in 11 healthy adult women (23). Hesperetin
and naringenin glycosides were found to be absorbed and eliminated very fast in humans
consuming OJ and were suggested to contribute significantly to the pool of total plasma
polyphenols known to be potent antioxidants (24,25).
The objective of the present study was to determine the effect of orange juice consumption on
the antioxidant status and risk markers including the measurement of circulating flavonoids,
carotenoids, vitamins A, C and E, folate, blood lipid profile, 8-hydroxy-deoxyguanosin (8OH-
dG), TBARS and homocysteine in thirteen healthy human subjects of both genders.
MATERIALS AND METHODS
Materials
HPLC analyses with diode array detection were carried out on a model 'Karat' chromatography
system including a binary pump model 125, an auto sampler model 507, and a multiple channel
diode-array detector model 168 (all units from Beckman; Fullerton, CA). Liquid
chromatography photo-diode array electrospray ionization mass spectrometry (LC/PDA/ESI-
MS) was carried out with a multiple channel diode-array detector and a quadrupole ion trap
mass spectrometer model LCQ Classic (ThermoElectron Corp., San Jose, CA). 8-
Hydroxydeoxyguanosine was analyzed on an Agilent Technologies 1100 binary pump,
autosampler, variable wavelength detector (Agilent Technology, San Diego, CA), and an ESA
Coulochem II electrochemical detector (ESA, Bedford, MA). Absorbance readings were
obtained from a DU-62 spectrophotometer (Beckman, Fullerton, CA). All solvents used for
HPLC and absorbance readings were analytical grade or HPLC grade from Fisher Scientific
(Fair Lawn, NJ). Butylated hydroxytoluene (BHT), hesperetin, hesperidin, naringenin,
naringin, and all other chemicals were purchased from Sigma Chemicals Co. (St. Louis, MO).
Subjects and Intervention Protocol
Thirteen healthy subjects, between 28−51 years of age (7 females and 6 males), of normal
height and weight, nonsmoking, not on any medication including hormones or dietary
supplements, without particular dietary patterns (e.g., vegetarians) consumed daily three 8
ounces of chilled not-from-concentrate orange juice (Tropicana Products, Inc., Bradenton, FL)
in addition to their usual diet, which subjects were recommended not to change during the
intervention. All procedures of the protocol were approved by the Institutional Review Board
(Committee on Human Subjects) of the University of Hawaii. Before entering the study, all
participants were informed about the protocol and signed the informed consent agreement.
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Collection of plasma and urine samples
On the morning before starting the intervention (baseline), after week 1 (day 8 of the
intervention), and after completion of the intervention (day 22 of the study) a blood sample
after fasting for at least 8 hours was drawn at 8 a.m. by venipuncture, and overnight urine was
collected. Blood was collected under subdued light into Na-heparin vacutainers followed by
immediate processing (plasma, white blood cells) in the dark at <8°C to avoid analyte
degradation. Urine was weighed and stored aliquoted at −70 °C.
Analysis of phytochemicals in orange juice, plasma, and urine
Carotenoid concentrations in juice were determined slightly modified from previous protocols
(26-28) by applying our previously established HPLC system (29). Final values were obtained
from peak areas using calibration curves of solutions of authentic standards and by adjustment
to internal standard recovery. Inter-assay coefficients of variation (cv) for beta-carotene, and
beta-cryptoxanthin were 9% and 8%, respectively, when analyzed from orange juice. Plasma
carotenoids, retinoids, and tocopherols were analyzed with the same HPLC system after
extraction from plasma as reported previously (29). Beta and gamma tocopherol were detected
together because these two compounds coelute in reverse-phase chromatography (30). Quality
of analysis was assured by participation in round robin tests organized by the National Institute
for Standards and Technologies (NIST, Gaithersburg, MD). Accuracy for the lipid soluble
vitamin assay was assured by participation in a quality assurance program organized by the
National Institute for Standards and Technologies (NIST), Gaithersburg, MD. Our results for
the main serum analytes did not exceed more than 1 standard deviation from the assigned value.
Precision of tr LUT/ZEA, cis LUT/ZEA, tr AH-LUT, cis AH-LUT, a-CRX, tr b-CRX, cis b-
CRX, LYC, DHLYC, a-CAR, tr b-CAR, cis b-CAR, total carotenoids, d-TOC, b+g-TOC, a-
TOC, and retinol was examined by an external plasma sample run every second batch (a total
of 9 runs) and revealed the following cv at the given mean concentrations: 7% at 219 μg/L, 9%
at 99 μg/L, 4% 62 μg/L, 8% at 37 μg/L, 9% at 32 μg/L, 7% at 56 μg/L, 13% at 30 μg/L, 8% at
195 μg/L, 17% at 47 μg/L, 7% at 25 μg/L, 10% at 138 μg/L, 11% at 17 μg/L, 4% at 909 μg/L,
17% at 685 μg/L, 8% at 515 μg/L, 5% at 11387 μg/L, and 5% at 413 μg/L.
Vitamin C content in the orange juice was analyzed by reversed phase HPLC with UV detection
(31). Inter-assay variation was found to be 4.8% using orange juice. Vitamin C concentrations
in plasma were analyzed colorimetrically using dichlorphenolindophenol (32). Quality of
analysis was assured by participation in round robin tests organized by NIST. Accuracy of this
assay was again assured by participation in a quality assurance program from NIST and
revealed deviations from the assigned value of not more than 7% at low concentrations ranging
from 18−24 μM. Folate concentrations in the orange juice and in plasma were analyzed using
the Bio-Rad Quantaphase II radioassay kit according to the instruction manual (Bio-Rad
Laboratories, Inc., Hercules, CA). Lymphochek serum controls I, II and III were run with each
batch of 40 samples. All samples and controls were run in duplicates. If cv was ≥10% samples
were reanalyzed. The intra- and inter-assay cv was 3.5% and 4.9% at 4.8 nM, 8.5% and 9.4%
at 11.6 nM, and <1% and 12.4% at 25.1 nM, respectively. of flavonoids and their glycoside
from orange juice were determined by RP-HPLC with diode-array detection without hydrolysis
as described in detail recently (33). Flavonoid concentrations from plasma and urine were
analyzed by LC/ESI-MS after enzymatic hydrolysis of glucuronide and sulfate conjugates to
their respective aglycones (hesperetin, naringenin) as described previously (34). Detection
limits were found to be 0.1−5 nmol/L depending on the analyte and inter- assay cv coefficients
of variations 8−22% at levels below 20 nmol/L, 7−14% at levels 20 nmol/L – 100 nmol/L, and
3−12% at levels over 100 nmol/L.
Spiking recovery from plasma for naringenin and hesperetin were found at 80% and 84%,
respectively; inter-assay cv were 8% (80.0 nM) and 6% (99.7 nM), respectively.
Franke et al. Page 3
J Agric Food Chem. Author manuscript; available in PMC 2008 September 9.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Triacylglycerol (TAG), HDL and total cholesterol concentrations in plasma were determined
by colorimetric procedures using kits #339, #352 and #352, respectively from Sigma Company.
LDL combined with VLDL cholesterol were computed using the Friedwald algorithm (total
cholesterol – HDL – (triacylglycerol/5) (35). Inter assay cv (n=6) for plasma TAG and total
cholesterol were 6.8% at 125 mg/dL and 4.6% at 200.0 mg/dL Homocysteine (HCy)
concentrations from plasma were determined by RP-HPLC with fluorescence detection after
pre-column derivatization with 7-fluror-2,1,3-benzoxadiazole-4-sulfonate (36). Inter-assay
coefficient of variations were 4−8% depending on the HCy concentration. Accuracy of this
assay was assured by comparison to values determined in an expert laboratory (Dr. Pfeiffer,
CDC). Our values in the concentration range 19−114 μM deviated from those determined in
the expert laboratory by 0.4% to 5.4%. Inter-assay cv ranged from 3.8% to 6.0% at 14.1−14.8
μM while inter-assay cv ranged 0.6% to 4.1% at 9.2−31.0 μM. 8-Hydroxydeoxyguanosine (8-
OHdG) in lymphocytes was determined by RP-HPLC with electrochemical detection after
DNA extraction from lymphocytes (37) . Inter-assay cv for the ratio 8OHdG/106dG was 6.2%.
Detection limits were 0.6 nmol/L and 10 μmol/L for 8OhdG and 106dG, respectively.
Thiobarbituric acids reactive substances (TBARS) in plasma were analyzed
spectrophotometrically and reported as malondialdehyde equivalents by reading the
differences of the 535 nm and 572 nm absorbance of the products formed from plasma
incubated with thiobarbituric acid reagent (38). This method avoids inclusion of false positive
readings by excluding artifacts formed during plasma processing.
Laboratory personnel was blinded to the treatment status of the samples.
Statistical analysis
Statistical evaluations regarding significance of changes from baseline were determined by
paired t-test calculations using Microsoft Excel software (Office 2001, Microsoft Corporation,
Redmond, WA) and by the Wilcoxon two sample rank sum tests using SAS software (SAS
Institute, Inc., Cary, NC).
RESULTS
The 4 batches of OJ used in this study were found to contain on average (mg/kg ±standard
deviation) 360 ±8.1 ascorbic acid, 8.1 ±0.16 carotenoids, 315 ±25.3 hesperidin, 7 ±0.7
hesperetin, 0.23 ±0.02 folate, 54 ±1.4 narirutin, and 6 ±1.8 narirutin (table 1). At a dose of 3
cups (24 oz or 236.6 mL) per day this corresponded to a daily intake of 1452 μmoles of ascorbic
acid, 12 μmoles of carotenoids, 0.37 μmoles folate, 383 μmoles hesperetin equivalents and 82
μmoles naringenin equivalents (citrus specific flavonoids). Among the carotenoids lutein and
other xanthophylls predominated (66%) followed by cryptoxanthins (19%) and carotenes
(15%). Approximately 90% of the xanthophylls were esterified compared to only 30% of the
cryptoxanthins. Among the carotene isomers only the beta-isomer could be detected. In
addition to beta-cryptoxanthin the alpha-isomer (21%) and cis-beta-isomer (13%) were
identified.
Plasma after fasting for at least 8 hours was analyzed at baseline, after week 1 (day 8), and at
the end of the intervention after week 3 (day 22). Significant changes were seen in some but
not all of the individual carotenoids contained in OJ (figure 1, table 2). Mean trans-lutein and
transzeaxanthin, reported together, significantly increased by 29% after week one from 271
μg/L to 350 μg/L and remained significantly elevated by 32% at week 3 (358 μg/L). A similar
trend was seen with trans-alpha-cryptoxanthin (33 μg/L to 55 μg/L to 70 μg/L) and trans-beta-
cryptoxanthin (124 μg/L to 196 μg/L to 240 μg/L) equivalent to a 112% and 94% increase after
the third week respectively. Also, concentrations of total cis-lutein plus cis-zeaxanthin,
reported together, and cis-beta-cryptoxanthin significantly increased by week 3 from 125 μg/
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L to 143 μg/L (a 15% increase) and from 36 μg/L to 54 μg/L (a 52% increase), respectively.
Changes in the plasma concentrations of trans-anhydrolutein, cis-anhydrolutein, total
lycopene, total dihydrolycopene and cis-beta carotene were not significant after 3 weeks (table
2). Alpha-carotene, and trans-beta-carotene increased significantly after week 1 but returned
to baseline concentrations after week 3. Plasma concentrations of total carotenoids significantly
increased by 20% from baseline (1282 μg/L) by week 1 (1537 μg/L) and remained significantly
elevated by 22% at week 3 (1568 mg/ml) (figure 1). There was no significant change in the
plasma concentrations of retinol or any of the tocopherols. Vitamin C and folate plasma
concentrations were significantly higher after week 1 (74.8 μmol/L=+62%; 55.7 μmol/L=
+44%), and after week 3 (73.1 μmol/L=+59% ; 56.5 μmol/L=+46%), than at baseline
(46.1μmol/L; 38.7 μmol/L), respectively (figure 2). Plasma concentrations of the flavonoids
hesperetin and naringenin were significantly increased after week 3 by 512% and 874%
respectively, from 3.3 nmol/L and 7.1 nmol/L, to 21.6 nmol/L and 68.7 nmol/L. The urinary
excretion rates (measured in nmol per mg creatinine) of hesperetin and naringenin were also
increased several fold and significantly increased by weeks 1 (21-fold and 4-fold) and week 3
(16-fold and 6-fold ) as compared with the baseline rates of 0.49 nmol/mg and 0.76nmol/mg,
respectively. Urinary excretion of these analytes 2 days after the end of this study decreased
back to baseline levels (data not shown). Mean homocysteine concentrations were elevated by
6% at week 3 (10.5 μmol/L, p=0.046) as compared with the baseline (9.9 μmol/L) (figure 3).
The mean 8-hydroxy deoxyguanosine:deoxyguanosine ratio, a marker of DNA damage was
decreased, albeit insignificantly, and concentrations of thiobarbituric acid reactive substances,
a marker of lipid oxidation, were almost unchanged (figure 3). Mean total cholesterol, HDL-
cholesterol, and LDL-cholesterol concentrations were also little changed but there was a
decrease in the mean LDL:HDL ratio by the end of the intervention (figure 4). This change,
however, was not statistically significant. The mean TAG concentration on the other hand was
significantly elevated by 26% at week 3 (1231 mg/L) as compared with the baseline (974 mg/
L) (figure 4).
DISCUSSION
In order to assess the effects of processing, handling methods, and storage conditions on the
change of vitamin C, flavonoid, and carotenoid content in OJ (39-41), we monitored the
concentration of these components in the OJ used during the trial. The micronutrient
concentrations of the chilled not-from-concentrate OJ determined in our study are generally in
agreement with those reported previously. There was minimal difference between the batches
used. The vitamin C content (360 mg/kg) is close to that reported in the U.S. Department of
Agriculture (USDA) food composition database (www.nal.usda.gov/fnic/foodcomp). For
example, chilled orange juices are listed to contain 330−427 mg/kg which is as expected lower
due to processing related losses compared to the orange fruit (498 mg/kg ) or raw freshly
squeezed juice (31). Carotenoid concentrations in raw juice were listed by USDA with almost
identical concentrations compared to our findings. The inclusion of many polar carotenoids
we included in the xanthophyll level caused most likely this value to be higher than the lutein/
zeaxanthin concentration reported by USDA. Orange fruits were reported with the same pattern
but with slightly lower absolute concentrations (41) which might be due to the non carotenoid
containing compartments in the fruits which are removed in the juice and therefore concentrate
carotenoids in the juice. In comparison with the total folate (290 mg/L) of chilled OJ listed in
the USDA database, our value (231 mg/kg) was slightly lower. Flavonoids (naringenin,
hesperetin) occur in OJ predominantly as glycosides (narirutin, hesperidin). The juice used in
our study was found to contain 322 mg/kg hesperetin based and 60 mg/kg naringenin based
flavanones. Less than 3% occurred as aglycones. These values are somewhat lower than those
reported by Manach et al. (444 mg/kg and 96 mg/kg , respectively) (24) but higher than those
found for 54 authentic orange juices (231±42 mg/kg and 19±121 mg/kg, respectively) (42) or
the juice of 14 different orange cultivar juices (122−254 mg/kg and 18−56, respectively)
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(43). This indicates that, as expected, variations in the content of the investigated
phytochemicals in different orange juices exist.
Subjects' weight did not change during this study (data not shown). The participants reported
lower intakes of snacks and smaller portion sizes of their meals due to consumption of the OJ
spread over the entire day but assured that their diet in general did not change. The
phytochemicals investigated and present in the OJ increased significantly in the circulation
including carotenoids, vitamin C, folate, and the orange specific flavanons hesperetin and
naringenin (fig. 1+2). While carotenoid and ascorbate concentrations in humans can be elevated
by the intake of a variety of fruits and vegetables only specific vegetarian foods provide
flavanones and the carotenoid cryptoxanthin. The elevation of circulating vitamin C
concentrations by OJ intake has been reported repeatedly (21-23) including the claim that a
citrus extract is superior compared to ascorbate supplements (44).
Our results showed a marked 22% and significant increase of circulating carotenoids after OJ
intake which are in good agreement with other intervention studies using juices (45,46).
Carotenoids are usually not well absorbed from the gut in the absence of lipids (10,47,48). The
high carotenoid exposure during the entire day, the consumption of juices during meals that
contained some fat, and the liquid nature of the exposure (presence of analytes in the dissolved
state), situations that applied all or partly in our intervention, could explain the significant
uptake of carotenoids into the circulation. In contrast to anemic schoolchildren who were found
to have increased serum beta-carotene concentrations after orange fruit consumption (49) we
did not observe a change in circulating alpha- or beta-carotene levels in our study. This might
be due to the shorter intervention period (3 versus 9 weeks) and more importantly, to the
differential nutritional status with the schoolchildren being malnourished while our study
population was extremely well nourished maintaining a typical healthy Western diet before
and during the study as estimated from interviews. Very few dietary items contain the
carotenoid cryptoxanthin, for example oranges, mandarins, apricots, and papaya (41). The
significant and very large increase (almost 100%) in plasma cryptoxanthins we observed in
our intervention is particularly noteworthy considering the associations of this carotenoid in a
case-control study with cervical cancer that showed a 20% and 70% decrease in risk between
the highest versus the lowest plasma beta-cryptoxanthin and alpha-cryptoxanthin
concentrations, respectively (50). In other, large epidemiologic studies dietary cryptoxanthin
exposure was shown to be associated with reduced lung cancer risk of 15−31% (10,11).
Similarly, protective effects were reported from Satsuma mandarins (Citrus unshiu Marc.),
rich in beta-cryptoxanthin (and also hesperidin), which suppressed chemically-induced lung
(51) and colon (52) carcinogenesis when fed to mice and rats, respectively.
Similar to the situation with cryptoxanthins few food plants produce significant amounts of
flavanones typically occurring in citrus fruits (hesperetin and naringenin usually as glycosides).
We found a several fold increase of plasma levels and urinary excretion of hesperetin during
the intervention which returned to baseline two days after study completion. This is in excellent
agreement with the fast pharmacokinetics of these flavonoids (24,34,53-55). We observed that
more naringenin compared to hesperetin related flavanones were retained in the circulation.
This is similar to our previous findings on the soy isoflavones genistein which is retained more
in the circulation and excreted at a lower rate than daidzein due to its lower polarity (56). The
health benefits of flavonoids have been intensively investigated (reviewed in (57)) and the
citrus flavanons are no exception (58). We reported earlier on the potent effect of citrus
flavonoids to inhibit neoplastic transformation (59) and also on their preventive effects on
formation of colonic aberrant crypt foci, a surrogate marker for colon cancer, in rats (60). In
addition to protecting against cancer, preventive effects for heart disease seem likely (61) but
conclusive results from epidemiologic and clinical studies are so far not available. Health
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benefits of these flavonoids are probably potentiated by combinations with other
phytochemicals occurring in plant foods, particularly carotenoids (51,52).
DNA damage in white blood cells decreased in our study by 16% and in individuals with high
baseline concentrations by 29% (n=7) however, this did not reach statistical significance. The
marker of lipid oxidation (TBARS) changed minimally. Intervention studies with single or
multiple supplementations of vitamin C, vitamin E, or carotenoids and those involving various
natural food products were found to yield mixed results (reviewed in (62)). In short-term
intervention studies (usually weeks or a few months), single-dosing studies found that
decreased oxidative (DNA) damage lasted only hours after antioxidant supplementation. Since
we collected plasma after subjects had been fasting for at least 8 hours we might have missed
the optimal time when the antioxidant effect was measurable.
In previous studies daily consumption of 8 fl. oz. OJ for a 2-week period or supplemental
vitamin C (approximately 70 mg/day) effectively raised circulating vitamin C and reduced
TBARS (23). But the investigated cohort had a very low vitamin C status (22−28 μmol/L) and
high TBARS readings at baseline rendering them susceptible to the expected changes.
Commercial fresh-squeezed OJ (500 mL/day) given to 12 subjects for 14 days increased plasma
concentrations of vitamin C and reduced concentrations of 8-epi-PGF(2)-alpha, another marker
for lipid oxidation (22). We did not measure this isoprostane in our study, and it is conceivable
that this marker reflects more selectively and sensitively changes in the systemic antioxidant
status. More importantly, we believe that our study population had a high antioxidant status at
baseline due to the high baseline levels of antioxidant micronutrients in plasma (see tables and
graphs), and their relatively low baseline levels of markers of oxidative damage. Therefore, an
increase in antioxidants in these subjects may lead to insignificant changes in markers of
oxidative damage. Previously, we determined repeatedly in nine individuals over a 3- month
period levels of TBARS and found positive correlations with plasma triglycerides and gamma-
tocopherol, and negative correlations with plasma carotenoids (63). The significant TAG
increase in this study (26%) may have led to higher TBARS and thereby offset the TBARS
lowering effect of the antioxidants. The increase in plasma TAG concentrations (26%) may be
due to the increase in total carbohydrate intake (64). The elevation did not pose a risk though
because it was well below critical values. A very similar increase in plasma TAG concentrations
(30%) was reported from an intervention trial that used the same, not-from concentrate OJ at
almost the same daily dose for 4-weeks with 25 hypercholesteremic subjects (21). In contrast
to that study, we found that mean total as well as HDL and LDL cholesterol concentrations did
not change markedly while the LDL:HDL ratio did favorably. However, no statistical
significance was reached for any of these changes. These discrepant results are probably due
to the different study population. OJ might be more effective in decreasing cholesterol levels
in hypercholesteremic but not in normochelesteremic subjects. This is similar to the effect seen
with soy protein exposure (65) and seems to be a desirable effect because lowering normal
levels could lead to critical ranges with potentially adverse outcomes.
Despite elevated folate concentrations (46% versus baseline) homocysteine (HCy)
concentrations in the circulation did not decrease in our study. We found surprisingly that total
HCy plasma concentrations increased (6%, p=0.05) which is in contrast to the traditional belief
that folate exposure will lower HCy concentrations (66). However, HCy was found to be
significantly higher in vegetarian subjects than in controls independent of folate status (67).
Also, C667T transitions in the methylenetetrahydrofolate reductase (MTHFR ) gene affect diet
responsiveness of plasma HCy upon folate exposure (68). About half of the interindividual
HCy variability in response to folic acid could be explained by basal HCy, age, male gender,
cigarette smoking, use of multivitamins, MTHFR or cystathionine beta-synthase
polymorphisms, but the other half could not be explained (69), and individual variability in
HCy response to folate depletion is much investigated (70). Our finding might therefore be
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due to cofounders including the possible change of the participants to a more plant based diet
during the intervention, the vast interindividual variation of HCy change upon folate exposure,
or a paradoxical response to folate intake (69). Our study did not allow stratification for these
variables. In addition, the HCy levels in our group were relatively low at baseline and therefore
difficult to reduce further. Furthermore, the high antioxidant status of our study population at
baseline, a possible saturation effect due to folic acid food fortification that took effect shortly
before this study started, the relatively short period of intervention, or other unknown factors
might also have contributed to our unusual finding. The present study shows a marked increase
in dietary antioxidants and a decrease in some but not all measured risk markers. Due to
theLimitations of this study are the relatively low numbers of participants, the relatively short
period of intervention, and the non-controlled diet. Although our interviews indicated no
significant changes in the diet during the intervention the present results of this study need to
be confirmed in larger trials with higher statistical power which could lead to more precise
conclusions regarding the effects of OJ on prevention of oxidative damage. The lack of
reduction in markers of oxidative damage in this study might be due to the high antioxidant
status of the participants at baseline, to changes in phytochemicals that do not affect the
measured markers, or are minor in comparison to the massive concentrations of other systemic
antioxidants (proteins, bilirubin, urate, etc.) (71). Despite our observation on increased HCy
and TAG levels, our results in combination with data from other OJ interventions suggest
strongly that OJ is an excellent food source to increase blood levels of a series of valuable
phytochemicals. These can then exert their activity by various mechanisms including a
decrease in oxidative damage to select biological targets and thereby protect against chronic
disorders especially, in at-risk populations with low antioxidant status. The increase in
circulating cryptoxanthins we observed for the first time after OJ exposure is particularly
intriguing because concentrations almost doubled in this study after delivery from juice which
is traditionally believed to be a route that leads to poor bioavailability of lipid phase
micronutrients. Therefore, we conclude that OJ is an excellent source to provide carotenoids
and flavonoids which occur in few fruits and vegetables at the same high levels and composition
and which may protect against cancer and other chronic diseases.
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b-+g TOC, beta and gamma tocopherol
b-CAR, trans beta-carotene
cis LUT/ZEA, total (cis-lutein+cis-zeaxanthin
cis AH-LUT, cis-anhydrolutein
cis b-CAR, cis beta-carotene
cis b-CRX, cis alpha-cryptoxanthin
CHOL, cholesterol
CRCH, Cancer Research Center of Hawaii
cv, coefficient(s) of variation
dG, deoxyguanosine
d-TOC, delta tocopherol
DH-LYC, total dihydrolycopene
HCy, homocysteine
HDL, high density lipoprotein
HPLC, high pressure liquid chromatography
LC, liquid chromatography
LC/MS, liquid chromatography mass spectrometry
LDL, low density lipoprotein
LYC, total lycopene
MTHFR, methylenetetrahydrofolate reductase
NIST, National Institute for Standards and Technologies
OJ, orange juice
PDA, photo diode array detection
TBARS, thiobarbituric acid reactive substances
TAG, triacylglycerols
tr-LUT/ZEA, trans-lutein+trans-zeaxanthin
tr-AH-LUT, trans-anhydrolutein
tr b-CRX, trans beta- cryptoxanthin
USDA, U.S. Department of Agriculture
UV/VIS, ultra-violet/visible
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Figure 1.
Mean plasma concentration change of individual and total carotenoids. t-LUT/ZEA=trans-
lutein+trans-zeaxanthin; cis-LUT/ZEA=total cis-lutein+cis-zeaxanthin; a-CRX= alpha-
cryptoxanthin; tr beta-CRX=trans beta-cryptoxanthin; cis beta-CRX=cis beta-cryptoxanthin;
a-CAR= alpha-carotene; tr beta-CAR=trans beta-carotene. White bars = baseline, striped bars
= after 1 week, black bars = after 3 weeks. Error bars indicate standard error. To convert into
μmol/L see legend of table 2. * p<0.05 for paired t-test comparing to baseline.
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Figure 2.
Mean change in plasma concentrations of ascorbic acid, folic acid, and the flavonoids
hesperetin and naringenin. Glucuronide and sulfate conjugates of flavonoids occurring in
plasma were enzymatically hydrolyzed prior to extraction and LC/MS analysis. White bars =
baseline, striped bars= after 1 week, black bars = after 3 weeks. Error bars indicate standard
error. * p<0.05 for paired t-test comparing to baseline.
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Figure 3.
Mean change of the 8-hydroxy deoxyguanosine (8 -OHdG)/deoxyguanosine (dG) ratio in white
blood cells and change in plasma concentrations of thiobarbituric acid reactive substances
(TBARS) and homocysteine (HCy). The latter values are 10 times greater than displayed in
graph. White bars = baseline, striped bars= after 1 week, black bars = after 3 weeks. Error bars
indicate standard error. TBARS units are malondialdehyde (MDA) equivalents. HCy values
were divided by 10 to fit scale of graph. * p<0.05 for paired t-test comparing to baseline.
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Figure 4.
Mean plasma concentration change of total, HDL and LDL cholesterol, and of triacylglycerols
(TAG). White bars = baseline, striped bars= after 1 week, black bars = after 3 weeks. Error
bars indicate standard error. To convert into μmol/L see legend of table 2. * p<0.05 for paired
t-test comparing to baseline.
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Table 1
Composition, dose, and variability of the not-from-concentrate OJ used in this study.
juice concentration Dose CV*
mg/kg mg/d μmol/d %
Vitamin C 360 255.5 1451.9 2.3%
Carotenoids 8.10 5.7 11.5 18.5%
Xanthophylls1 5.40 3.8 6.7 18.1%
Cryptoxanthins2 1.59 1.1 2.0 16.2%
Trans beta-carotene 0.40 0.3 0.5 22.2%
Hesperidin+Hesperetin 322 228.6 382.7 7.1%
Narirutin 60 42.6 81.7 2.5%
Folate 0.23 0.16 0.37 9.2%
*
coefficient of variation between 2 different batches of juice and 4 different samples
1
mainly lutein and zeaxanthin
2
75% trans beta-cryptoxanthin, 6% cis beta-cryptoxanthin, 19% alpha-cryptoxanthin
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Table 2
Baseline concentrations and mean changes in the circulation during this study
level at baseline changeversusbaseline
1 week (p-value*) 3 weeks (p-value*)
tr LUT/ZEA (μg/L) 270.5 29% (0.041) 32% (0.001)
cis LUT/ZEA (μg/L) 124.6 5% (0.359) 15% (0.034)
tr AH-LUT (μg/L) 64.3 −3% (0.336) −1% (0.741)
cis AH-LUT (μg/L) 44.3 −4% (0.443) 2% (0.675)
a-CRX (μg/L) 33.1 67% (<0.001) 112% (<0.001)
tr b-CRX (μg/L) 123.7 58% (<0.001) 94% (<0.001)
cis b-CRX (μg/L) 35.8 12% (0.059) 52% (<0.001)
LYC (μg/L) 230.0 −9% (0.027) 5% (0.624)
DH-LYC (μg/L) 64.5 −14% (0.015) −3% (0.715)
a-CAR (μg/L) 79.1 21% (0.034) 8% (0.387)
tr b-CAR (μg/L) 198.9 14% (0.039) −4% (0.549)
cis b-CAR (μg/L) 13.1 −3% (0.555) −3% (0.612)
Total Carotenoids (μg/L) 1281.9 20% (0.004) 22% (<0.001)
Retinol (μg/L) 746.4 15% (0.121) 16% (0.051)
d-TOC (μg/L) 405.1 −3% (0.051) −20% (0.051)
b+g-TOC (μg/L) 1566.3 −5% (0.523) −6% (0.558)
a-TOC (μg/L) 8159.0 0% (0.979) 4% (0.349)
Ascorbic acid (μmol/L) 46.7 62% (<0.001) 59% (<0.001)
Folic acid (nmol/L) 38.7 44% (0.013) 46% (0.018)
Hesperetin (nmol/L) 3.3 1016% (0.227) 657% (0.045)
Naringenin (nmol/L) 7.1 612% (0.113) 974% (0.044)
8OHdG/106dG 0.2 −5% (0.755) −16% (0.204)
TBARS (μmol/L MDA) 0.2 0% (0.970) 2% (0.795)
HCy (μmol/L) 9.9 5% (0.124) 6% (0.046)
HDL-CHOL (mg/L) 431.4 −1% (0.814) −1% (0.743)
LDL-CHOL (mg/L) 1286.7 −3% (0.365) −5% (0.350)
Total CHOL (mg/L) 1912.9 0% (0.986) −1% (0.827)
TAG (mg/L) 974.0 22% (0.147) 26% (0.016)
LDL/HDL 3.3 −3% (0.474) −3% (0.498)
t-LUT/ZEA=trans-lutein+trans-zeaxanthin (μg/L), cis-LUT/ZEA=total (cis-lutein+cis-zeaxanthin,t-AH-LUT=trans-anhydrolutein, cis-AH-LUT=cis-
anhydrolutein, a-CRX=trans-alpha- cryptoxanthin, tr b-CRX=trans beta-cryptoxanthin, cis b-CRX=cis alpha-cryptoxanthin, LYC=total lycopene, DH-
LYC=total dihydrolycopene, a-CAR=trans alpha-carotene, b-CAR=trans beta-carotene, cis b-CAR=cis beta-carotene, d-TOC=delta tocopherol, b-+g
TOC=beta and gamma tocopherol, 8OHdG=8-hydroxydeoxyguanosin, TBARS=thiobarbituric acid reactive substances. HCy=homocysteine,
CHOL=cholesterol, TAG=triacylglycerols; HDL=high density lipoprotein, LDL=low density lipoprotein. To convert into μmol/L multiply μg/L by
0.00176 (LUT/ZEA), 0.00181 (CRX), 0.00187 (CAR, LYC), 0.00349 (Retinol), 0.00232 (aTOC), 0.00240 (b+gTOC), 0.00248 (dTOC) or multiply mg/
L by 2.59 (CHOL) and 1.13 (TAG), or divide nmol/L by 1000.
*
p-value determined by student's paired t-test, bold indicates p<0.05.
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